There is a source of dietary phosphorus that has been noted
but is largely unrecognized and unquantified—the phosphorus content of
prescription medications. That drugs may contain phosphorus is clear, as it is
indicated on the list of inert ingredients reported on their package label. Sherman
et al few years back did an amazing study that showcased that medication
preservatives might have phosphorus content that we don’t recognize. This might
be also causing some phosphorus rises in our patients and need for increased
binders.
Medication and dose
|
Manufacturer
|
Phosphorus content
|
Amt of Phos binders required
additional
|
Lisinopril 10mg
|
Qualitest
|
40.1mg
|
2
|
Lisinopril 10mg
|
Blue Point labs
|
32.6mg
|
1.5
|
Amlodipine 10mg
|
Greenstone
|
27.8mg
|
1
|
Amlodipine 10mg
|
Lupin
|
8.6mg
|
-
|
Paroxetine
|
Glaxosmith Kline
|
111.5mg
|
5
|
Paroxetine
|
Cadila
|
22.7mg
|
1
|
Renavite
|
Cypress
|
37.7mg
|
1
|
Renocaps
|
Nnodum
|
1.7mg
|
-
|
How do we help our patients with this information? Better
would be some way of making prescribers aware that their prescribed medications
may be high in phosphorus—they are not ‘dialysis safe’.
Perhaps creating a database of all drugs and
their phosphorus content might be useful.
Or is this not consequential to our patients as diet is the biggest
factors… the above is just the sample of drugs the author had inquired..
imagine the rest of the medications and other chemotherapy and other
anitbiotics we give our patients.
This comment has been removed by a blog administrator.
ReplyDelete